中文名稱  磷酸化核轉(zhuǎn)錄因子NFKB-RelB蛋白抗體品牌 

英文名稱  Anti-Phospho-RelB(Ser573)

別    名 RelB(Phospho-Ser573); RELB(phospho S573); I REL; IREL; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; RelB; Reticuloendotheliosis viral oncogene homolog B; Transcription factor RelB; v rel avian reticuloendotheliosis viral oncogene homolog; v rel reticuloendotheliosis viral oncogene homolog B; RELB_HUMAN; I-Rel.

產(chǎn)品屬性：

磷酸化核轉(zhuǎn)錄因子NFKB-RelB蛋白抗體品牌 濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep, Guinea Pig

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     細胞生物 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 細胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量  predicted molecular weight: 64kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human RelB around the phosphorylation site of Ser573

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化核轉(zhuǎn)錄因子NFKB-RelB蛋白抗體品牌 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The NFKB complex consists of NFKB1 or NFKB2 bound to REL, RELA, or RELB. The NFKB complex is inhibited by I kappa B proteins (NFKBIA, or NFKBIB), which inactivate NF kappa B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I kappa B proteins by kinases (IKBKA, or IKBKB,) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF kappa B complex. For some genes, activation requires NFKB interaction with other transcription factors, such as STAT, AP1 (JUN), and NFAT.

Function : NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment.

Subunit : Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates; the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.

Subcellular Location : Nucleus. Cytoplasm, cytoskeleton, centrosome. Note=Co-localizes with NEK6 in the centrosome.

Post-translational modifications : Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation.

Similarity : Contains 1 RHD (Rel-like) domain.

Database links : UniProtKB/Swiss-Prot: Q01201.2

實驗流程：

全、新、優(yōu)、品、好四大特點：

磷酸化核轉(zhuǎn)錄因子NFKB-RelB蛋白抗體品牌 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

技術(shù)外包服務(wù):

★磷酸化核轉(zhuǎn)錄因子NFKB-RelB蛋白抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。

正在熱銷的相關(guān)產(chǎn)品：

lamin A 核纖層蛋白A抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-phospho-ALK/CD246(Tyr1278/1282/1283) 磷酸化間變型激酶抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh phospho-c-Abl(Tyr204) 磷酸化非受體酪氨酸激酶c-Abl抗體 規(guī)格 0.1ml

品名 規(guī)格 備注

Vitamin A 英文名稱： 維生素A抗體 0.1ml

phospho-DAXX (Ser213) 英文名稱： 磷酸化Fas相關(guān)死亡結(jié)構(gòu)域蛋白抗體 0.1ml

Anti-phospho-ALK/CD246(Tyr1278/1282/1283) 磷酸化間變型激酶抗體Multi-class antibodies規(guī)格： 0.1ml

Anti-PIWIL1/FITC 熒光素標(biāo)記piwi樣1蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rabbit Anti-Meiiones Unguiculataus Milme-Edwauds 兔抗長爪沙鼠IgG (親和層析純化)Multi-class antibodies規(guī)格： 1mg

透明質(zhì)酸酶/玻璃酸酶抗體 Anti-Haase 0.2ml

Dog IgM/AP 堿性磷酸酶(AP)標(biāo)記的兔抗犬IgM抗體 0.1ml

FAM21C 英文名稱： FAM21C蛋白抗體 0.2ml

Rhesus antibody Rh phosphor-SMAD2(Ser425) 磷酸化細胞信號轉(zhuǎn)導(dǎo)分子SMAD2抗體 規(guī)格 0.1ml

Rabbit Anti-Meiiones Unguiculataus Milme-Edwauds 兔抗長爪沙鼠IgG (親和層析純化)Multi-class antibodies規(guī)格： 1mg

SEZ6L 英文名稱： 樣相關(guān)蛋白6抗體 0.1ml

phospho-ERK1 + 2 (Thr183/185) 英文名稱： 磷酸化原活化蛋白激酶1/2抗體 0.1ml

鈣激活的中性蛋白酶2抗體 Anti-Calpain 2 0.1ml

Anti-VTG/HRP 辣根過氧化物酶標(biāo)記兔抗魚、青鳉魚卵黃蛋白原抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-HSP27 (Ser254) 磷酸化熱休克蛋白27抗體 規(guī)格 0.1ml

CBFA1/RUNX2 (Runt-related Transcription Factor 2) 成骨特異性轉(zhuǎn)錄因子(多肽)Multi-class antibodies規(guī)格： 0.5mg

人羊膜間充質(zhì)基質(zhì)細胞

C2C12 小鼠成肌細胞

IGFBP6 Others Mouse 小鼠 IGFBP6 / IBP-6 人細胞裂解液 (陽性對照)

CL-0110HL-60(人早幼粒急性細胞)5×106cells/瓶×2

人真皮成纖維細胞-新生兒裂解物HDF-n L

人胚腎細胞(SV40T基因修飾);293T/17 人主動脈內(nèi)皮細胞完全培養(yǎng)基 100mL

CL-0111HL-7702(人肝正常細胞)5×106cells/瓶×2

IgG2b Others Mouse 小鼠 IgG2b-Fc 人細胞裂解液 (陽性對照)

小鼠胃粘膜上皮細胞完全培養(yǎng)基 100mL

OP9小鼠骨髓基質(zhì)細胞 OP9 mouse bone marrow somal cells a-MEM培養(yǎng)基+20%FBS

LIF Protein Mouse 重組小鼠 LIF 蛋白 (His 標(biāo)簽)

RT4(人膀胱移行細胞瘤細胞) 5×106cells/瓶×2 T-24(膀胱變移細胞癌)

磷酸化核轉(zhuǎn)錄因子NFKB-RelB蛋白抗體品牌 人羊膜間充質(zhì)基質(zhì)細胞

C2C12 小鼠成肌細胞

IGFBP6 Others Mouse 小鼠 IGFBP6 / IBP-6 人細胞裂解液 (陽性對照)

CL-0110HL-60(人早幼粒急性細胞)5×106cells/瓶×2

人真皮成纖維細胞-新生兒裂解物HDF-n L

人胚腎細胞(SV40T基因修飾);293T/17 人主動脈內(nèi)皮細胞完全培養(yǎng)基 100mL